搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Jannaschia sp. Gamma-glutamyl phosphate reductase (proA) CSB-YP636800JAAA
CSB-EP636800JAAA
CSB-BP636800JAAA
CSB-MP636800JAAA
CSB-EP636800JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Phosphoribosylformylglycinamidine synthase 2 (purL), partial CSB-YP636801JAAA
CSB-EP636801JAAA
CSB-BP636801JAAA
CSB-MP636801JAAA
CSB-EP636801JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Glucose-6-phosphate isomerase (pgi), partial CSB-YP636802JAAA
CSB-EP636802JAAA
CSB-BP636802JAAA
CSB-MP636802JAAA
CSB-EP636802JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B (gatB), partial CSB-YP636803JAAA
CSB-EP636803JAAA
CSB-BP636803JAAA
CSB-MP636803JAAA
CSB-EP636803JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans Carboxylate-amine ligase Rmet_3485 (Rmet_3485) CSB-YP636804RJG
CSB-EP636804RJG
CSB-BP636804RJG
CSB-MP636804RJG
CSB-EP636804RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans 50S ribosomal protein L11 (rplK) CSB-YP636805RJG
CSB-EP636805RJG
CSB-BP636805RJG
CSB-MP636805RJG
CSB-EP636805RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans 50S ribosomal protein L3 (rplC) CSB-YP636806RJG
CSB-EP636806RJG
CSB-BP636806RJG
CSB-MP636806RJG
CSB-EP636806RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans 30S ribosomal protein S3 (rpsC) CSB-YP636807RJG
CSB-EP636807RJG
CSB-BP636807RJG
CSB-MP636807RJG
CSB-EP636807RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans 50S ribosomal protein L18 (rplR) CSB-YP636808RJG
CSB-EP636808RJG
CSB-BP636808RJG
CSB-MP636808RJG
CSB-EP636808RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans DNA-directed RNA polymerase subunit alpha (rpoA) CSB-YP636809RJG
CSB-EP636809RJG
CSB-BP636809RJG
CSB-MP636809RJG
CSB-EP636809RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans ATP phosphoribosyltransferase (hisG) CSB-YP636810RJG
CSB-EP636810RJG
CSB-BP636810RJG
CSB-MP636810RJG
CSB-EP636810RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans 2-nonaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase (coq7) CSB-YP636811RJG
CSB-EP636811RJG
CSB-BP636811RJG
CSB-MP636811RJG
CSB-EP636811RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC) CSB-YP636812RJG
CSB-EP636812RJG
CSB-BP636812RJG
CSB-MP636812RJG
CSB-EP636812RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans GTPase obg (obg) CSB-YP636813RJG
CSB-EP636813RJG
CSB-BP636813RJG
CSB-MP636813RJG
CSB-EP636813RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans Dihydrodipicolinate reductase (dapB) CSB-YP636814RJG
CSB-EP636814RJG
CSB-BP636814RJG
CSB-MP636814RJG
CSB-EP636814RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP636815RJG
CSB-EP636815RJG
CSB-BP636815RJG
CSB-MP636815RJG
CSB-EP636815RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans Imidazolonepropionase (hutI) CSB-YP636816RJG
CSB-EP636816RJG
CSB-BP636816RJG
CSB-MP636816RJG
CSB-EP636816RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans Putative Holliday junction resolvase (Rmet_2742) CSB-YP636817RJG
CSB-EP636817RJG
CSB-BP636817RJG
CSB-MP636817RJG
CSB-EP636817RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans 6,7-dimethyl-8-ribityllumazine synthase (ribH) CSB-YP636818RJG
CSB-EP636818RJG
CSB-BP636818RJG
CSB-MP636818RJG
CSB-EP636818RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans GTP cyclohydrolase folE2 2 (folE2-2) CSB-YP636819RJG
CSB-EP636819RJG
CSB-BP636819RJG
CSB-MP636819RJG
CSB-EP636819RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>